Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Clin Pharmacol ; 82(5): 1371-1381, 2016 11.
Article in English | MEDLINE | ID: mdl-27331367

ABSTRACT

AIMS: In drug development, the anti-inflammatory properties of new molecules in the lung are currently tested using the inhaled lipopolysaccharide (LPS) model. The total and regional lung bioavailability of inhaled particles depends significantly on their size. The objective of the present study was to compare inflammatory responses in healthy volunteers after the inhalation of LPS of varying droplet size. METHODS: Three nebulizers were characterized by different droplet size distributions [mean mass median aerodynamic diameters: Microcirrus (2.0 µm), MB2 (3.2 µm) and Pari (7.9 µm)]. Participants inhaled three boluses of a 20 µg (technetium 99 m-labelled) solution of LPS, randomly delivered by each nebulizer. We measured the lung deposition of the nebulized LPS by gamma-scintigraphy, while blood and sputum biomarkers were evaluated before and after challenges. RESULTS: MB2 and Pari achieved greater lung deposition than Microcirrus [171.5 (±72.9) and 217.6 (±97.8) counts pixel-1 , respectively, vs. 67.9 (±20.6) counts pixel-1 ; P < 0.01]. MB2 and Pari caused higher levels of blood C-reactive protein and more total cells and neutrophils in sputum compared with Microcirrus (P < 0.05). C-reactive protein levels correlated positively with lung deposition (P < 0.01). CONCLUSIONS: Inhalation of large droplets of LPS gave rise to greater lung deposition and induced a more pronounced systemic and bronchial inflammatory response than small droplets. The systemic inflammatory response correlated with lung deposition. NCT01081392.


Subject(s)
C-Reactive Protein/metabolism , Inflammation/chemically induced , Lipopolysaccharides/pharmacokinetics , Neutrophils/drug effects , Particle Size , Technetium/pharmacokinetics , Administration, Inhalation , Adolescent , Adult , Cell Count , Female , Healthy Volunteers , Humans , Inflammation/metabolism , Lipopolysaccharides/administration & dosage , Lung/metabolism , Male , Middle Aged , Nebulizers and Vaporizers , Radionuclide Imaging , Sputum/cytology , Technetium/administration & dosage , Young Adult
2.
BMC Pharmacol Toxicol ; 15: 60, 2014 Nov 03.
Article in English | MEDLINE | ID: mdl-25371053

ABSTRACT

BACKGROUND: Inhaled endotoxin induces airways'neutrophilia, in human. TNF-a being a key cytokine in the response to endotoxin, the effect of anti-TNF on the endotoxin-induced neutrophilic response was evaluated among healthy volunteers. METHODS: Among a population of 30 healthy subjects, an induced-sputum was collected 2 weeks before, and 24 hours after an inhalation of 20 mcg endotoxin (E. coli 026:B6). Then, the subjects were randomized into 3 parallel groups treated with control, oral methylprednisolone 20 mg/day during 7 days or anti-TNF (adalimumab, Humira®, Abbott) 40 mg s.c.. One week later, an induced-sputum was sampled, 24 hours after an inhalation of endotoxin. RESULTS: After endotoxin inhalation, the number of total cells, neutrophils and macrophages was significantly increased (p <0.001). Compared to the response to endotoxin among the control group, anti-TNF inhibited the endotoxin-induced neutrophil influx, both in relative (51.3 (±6.4)% versus 26.2 (±5.3)%, p <0.002) and in absolute values (1321 (443-3935) cells/mcL versus 247 (68-906) cells/mcL, p <0.02). The endotoxin-induced neutrophilic response was not significantly modified among the control group and oral corticosteroid group. CONCLUSIONS: While oral corticosteroid had no effect, anti-TNF inhibited the neutrophil influx in sputum, induced by inhalation of endotoxin, in human subject. The endotoxin model could be an early predictor of clinical efficacy of novel therapeutics. TRIAL REGISTRATION: ClinicalTrials.gov NCT02252809 (EudraCT2008-005526-37).


Subject(s)
Antibodies, Monoclonal, Humanized/pharmacology , Inflammation/immunology , Neutrophils/drug effects , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adalimumab , Administration, Inhalation , Adult , Cell Count , Escherichia coli , Female , Humans , Inflammation/chemically induced , Lipopolysaccharides , Macrophages/drug effects , Macrophages/immunology , Male , Methylprednisolone/pharmacology , Neutrophils/immunology , Sputum/cytology
3.
Br J Clin Pharmacol ; 72(6): 912-20, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21595743

ABSTRACT

AIM: Pharmacological profiling techniques, such as the cantharidin-induced skin blister, may be used to assess the anti-inflammatory properties of novel drugs. However, no data are available on the reproducibility of this technique or on the blocking effect of anti-inflammatory drugs, such as anti-TNF and corticosteroids. METHODS: A group of 30 healthy subjects were randomized into three parallel groups treated with placebo, oral methylprednisolone 20 mg day(-1) for 7 days or anti-tumour necrosis factor (TNF) (adalimumab, Humira®, Abbott) 40 mg s.c. single dose. A first blister was induced at baseline and collected, immediately before the start of treatment and a second blister was obtained 7 days after the start of treatment. The total number of cells, the cell viability and the differential cell count were evaluated by two independent observers, who were blind to treatment. anova was used to compare change from baseline among the three groups before pairwise comparisons. RESULTS: Among the placebo group, there was no significant difference in the total cell count, neutrophils, eosinophils and monocytes between day 1 and day 7. Methylprednisolone inhibited the eosinophil influx in mean % (95% CI) (-1.0 (-1.7, -0.3); P < 0.02) and absolute (P < 0.02) values, while anti-TNF inhibited the neutrophil influx in mean % (95% CI) (-19.3 (-29.5, -9.1); P < 0.01) and absolute (P < 0.05) values. CONCLUSIONS: The cantharidin-induced skin blister is a safe, well tolerated and reproducible procedure. Pre-treatment with anti-TNF or methylprednisolone inhibited the neutrophilic or eosinophilic trafficking, respectively. It could be useful in profiling anti-inflammatory drugs regarding their effects on the cellular inflammatory response.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Blister/chemically induced , Cantharidin/toxicity , Inflammation/chemically induced , Adalimumab , Adult , Antibodies, Monoclonal, Humanized/pharmacology , Blister/drug therapy , Blister/pathology , Eosinophils/drug effects , Eosinophils/metabolism , Female , Humans , Inflammation/drug therapy , Inflammation/pathology , Irritants/toxicity , Male , Methylprednisolone/pharmacology , Models, Biological , Neutrophils/drug effects , Neutrophils/metabolism , Reproducibility of Results , Skin/pathology , Tumor Necrosis Factor-alpha/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...